Pharmacogenomics (PGx) is the study of gene-drug interactions and utilizes individuals’ genomic profiles to identify those who are at greater risk for adverse drug reactions or ineffectiveness.

The page provides treatment modifications and drug dosage adjustment information based on Clinical Pharmacogenetics Implementation Consortium (CPIC) and Dutch Pharmacogenomics Working Group (DPWG) guidelines and recommendations.

Patients’ genotype for drug-related genes and particularly actionable pharmacovariants would be available for clinicians and physicians alongside the relevant recommendations for therapeutic amendments and revisions.

Once you entered your personal and unique PIN code, your doctor or pharmacist has the access to your personalized page just for one-time use. When you close the page, it will automatically get out of your personal page.

Your data is completely secured and protected. It is only available for you and your doctor. Access to data is protected by individual PIN code that is known only by owner of the card. The whole communication is protected by HTTPS protocol with required security settings.

If you have a QR reader (for example on your mobile phone or PC computer), just use it on your personal UMB_PGx card. It will redirect you to the PIN code page. You just need to enter your PIN code and the guidelines would be available subsequently. If you don’t have QR code reader, then simply ask your doctor to enter the https://clinicalpgx.pl/ and use the card number which is indicated under the QR code on your UMB_PGx card.

All the medical staff of clinicalpgx.pl are academic members who are specialized and highly trained in the field of Pharmacogenomics, genomic medicine, and individualized treatment. The related peer reviewed article, which explained the scientific approaches in providing data is published and freely available on https://www.nature.com/articles/s41397-022-00286-4 (DOI:10.1038/s41397-022-00286-4).